uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
41.81
-3.36 (-7.44%)
At close: Jul 2, 2026, 4:00 PM EDT
43.00
+1.19 (2.85%)
Pre-market: Jul 6, 2026, 5:56 AM EDT
uniQure Market Cap
uniQure has a market cap or net worth of $2.87 billion as of July 6, 2026. Its market cap has increased by 255.02% in one year.
Market Cap
2.87B
Enterprise Value
2.83B
1-Year Change
255.02%
Ranking
Category
Stock Price
$41.81
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $2.87B, an increase of 1,684.37%. That is a compound annual growth rate of 36.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.64B | 76.90% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 3.29B |
| Arcutis Biotherapeutics | 3.23B |
| Celldex Therapeutics | 3.01B |
| Vera Therapeutics | 2.96B |
| Disc Medicine | 2.91B |
| Kailera Therapeutics | 2.85B |
| Tarsus Pharmaceuticals | 2.82B |
| SELLAS Life Sciences Group | 2.79B |